Ning Gao Selected Research

Cefpodoxime Proxetil (Vantin)

1/2021	Ceftazidime-Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime-ETX1317 Susceptibility.
1/2021	Interactions of the Diazabicyclooctane Serine β-Lactamase Inhibitor ETX1317 with Target Enzymes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ning Gao Research Topics

Disease

61	Neoplasms (Cancer) 05/2022 - 08/2002
17	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2011
15	Leukemia 01/2021 - 10/2004
9	Inflammation (Inflammations) 01/2022 - 06/2013
9	Carcinoma (Carcinomatosis) 12/2018 - 08/2002
8	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 02/2010
8	Carcinogenesis 01/2021 - 08/2002
5	Infections 01/2021 - 04/2005
5	Hypoxia (Hypoxemia) 01/2015 - 08/2002
4	Neoplasm Metastasis (Metastasis) 05/2020 - 10/2010
4	Ischemic Stroke 03/2020 - 02/2018
4	B-Cell Lymphoma (Lymphoma, B Cell) 11/2019 - 01/2017
4	Stomach Neoplasms (Stomach Cancer) 07/2019 - 01/2013
4	Squamous Cell Carcinoma of Head and Neck 01/2014 - 04/2005
3	Hyperhomocysteinemia 05/2021 - 11/2020
3	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 12/2018
3	Pneumonia (Pneumonitis) 01/2020 - 12/2014
3	Adenoid Cystic Carcinoma (Cylindroma) 10/2014 - 04/2010
3	Oral Leukoplakia 11/2009 - 12/2008
2	Triple Negative Breast Neoplasms 01/2022 - 05/2019
2	Fibrosis (Cirrhosis) 05/2021 - 04/2011
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2021 - 07/2019
2	Ischemia 02/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2021 - 03/2013
2	Bone Resorption 12/2020 - 07/2019
2	Dry Eye Syndromes (Dry Eye Syndrome) 11/2020 - 01/2020
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2020 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2020 - 01/2017
2	Cataract (Cataracts) 01/2020 - 08/2017
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 02/2018
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2018 - 01/2017
2	Hypersensitivity (Allergy) 01/2018 - 12/2016
2	Mouth Neoplasms (Oral Cancer) 01/2014 - 01/2014
2	Hematologic Neoplasms (Hematological Malignancy) 11/2013 - 04/2006

Drug/Important Bio-Agent (IBA)

13	Pharmaceutical PreparationsIBA 05/2020 - 07/2011
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
9	Biological ProductsIBA 01/2021 - 12/2008
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 08/2002
7	MicroRNAs (MicroRNA)IBA 05/2021 - 06/2011
6	Actin Depolymerizing Factors (Cofilins)IBA 01/2022 - 07/2013
5	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 10/2004
5	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2010
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2016
5	CytokinesIBA 07/2019 - 11/2017
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015 - 01/2004
5	CaspasesIBA 11/2013 - 01/2006
4	ParaffinIBA 05/2021 - 02/2014
4	Peptides (Polypeptides)IBA 02/2021 - 12/2015
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
4	Phosphotransferases (Kinase)IBA 02/2020 - 04/2006
4	Cytochromes c (Cytochrome c)IBA 01/2018 - 01/2006
3	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 06/2017
3	Folic Acid (Vitamin M)FDA LinkGeneric 05/2021 - 11/2020
3	LigandsIBA 01/2021 - 03/2006
3	Capsules (Microcapsules)IBA 01/2020 - 10/2010
3	Oxygen (Dioxygen)IBA 01/2020 - 01/2018
3	Interleukin-17 (Interleukin 17)IBA 07/2019 - 08/2018
3	Messenger RNA (mRNA)IBA 07/2019 - 03/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2015
3	CyclinsIBA 08/2017 - 10/2003
3	EnzymesIBA 06/2013 - 10/2003
3	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2012 - 10/2003
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2006 - 08/2004
2	GoldIBA 03/2022 - 03/2015
2	C-Reactive ProteinIBA 01/2022 - 08/2018
2	cepharanthineIBA 01/2022 - 11/2019
2	HomocysteineIBA 05/2021 - 01/2021
2	QuercetinIBA 01/2021 - 12/2010
2	Long Noncoding RNAIBA 01/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2012
2	fibrin fragment D (D-dimer)IBA 01/2021 - 08/2018
2	Cefpodoxime Proxetil (Vantin)FDA LinkGeneric 01/2021 - 01/2021
2	Sirolimus (Rapamycin)FDA Link 11/2020 - 08/2004
2	artenimol (dihydroartemisinin)IBA 05/2020 - 05/2011
2	Cytochrome P-450 CYP3AIBA 03/2020 - 10/2003
2	Proteolysis Targeting ChimeraIBA 01/2020 - 11/2018
2	snake venom protein C activatorIBA 01/2020 - 11/2018
2	3-methylquercetinIBA 05/2019 - 01/2018
2	Estrogens (Estrogen)FDA Link 05/2019 - 04/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2018 - 02/2010
2	Coloring Agents (Dyes)IBA 02/2018 - 01/2017
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2018 - 01/2015
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 01/2018
2	Cyclin D1IBA 08/2017 - 08/2004
2	pyrimidineIBA 01/2017 - 01/2017
2	RNA (Ribonucleic Acid)IBA 04/2016 - 01/2010
2	AntigensIBA 04/2016 - 12/2014
2	AcetylcholinesteraseIBA 11/2015 - 10/2014
2	shogaolIBA 11/2013 - 01/2012
2	IronIBA 10/2013 - 02/2011

Therapy/Procedure

13	Therapeutics 04/2021 - 12/2008
7	Drug Therapy (Chemotherapy) 05/2021 - 12/2009
5	Injections 06/2019 - 12/2008
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 12/2018
3	Precision Medicine 01/2017 - 01/2015
3	Radiotherapy 09/2013 - 04/2005
2	Neck Dissection (Radical Neck Dissection) 12/2021 - 12/2018
2	Ligation 12/2021 - 03/2006
2	Intravitreal Injections 01/2021 - 04/2018
2	Electrodes (Electrode) 02/2020 - 01/2006